nodes	percent_of_prediction	percent_of_DWPC	metapath
Phendimetrazine—Stomach ache—Mitoxantrone—lymphatic system cancer	0.0682	0.0682	CcSEcCtD
Phendimetrazine—Sweating—Teniposide—lymphatic system cancer	0.0297	0.0297	CcSEcCtD
Phendimetrazine—Dysuria—Fludarabine—lymphatic system cancer	0.0286	0.0286	CcSEcCtD
Phendimetrazine—Flushing—Teniposide—lymphatic system cancer	0.0258	0.0258	CcSEcCtD
Phendimetrazine—Anorexia—Mechlorethamine—lymphatic system cancer	0.0256	0.0256	CcSEcCtD
Phendimetrazine—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.0233	0.0233	CcSEcCtD
Phendimetrazine—Agitation—Teniposide—lymphatic system cancer	0.0223	0.0223	CcSEcCtD
Phendimetrazine—Agitation—Fludarabine—lymphatic system cancer	0.0196	0.0196	CcSEcCtD
Phendimetrazine—Tachycardia—Teniposide—lymphatic system cancer	0.0193	0.0193	CcSEcCtD
Phendimetrazine—Abdominal pain upper—Mitoxantrone—lymphatic system cancer	0.0192	0.0192	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Teniposide—lymphatic system cancer	0.0191	0.0191	CcSEcCtD
Phendimetrazine—Anorexia—Teniposide—lymphatic system cancer	0.0189	0.0189	CcSEcCtD
Phendimetrazine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.0184	0.0184	CcSEcCtD
Phendimetrazine—Dysuria—Vincristine—lymphatic system cancer	0.0175	0.0175	CcSEcCtD
Phendimetrazine—Decreased appetite—Teniposide—lymphatic system cancer	0.0172	0.0172	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.0168	0.0168	CcSEcCtD
Phendimetrazine—Flushing—Bleomycin—lymphatic system cancer	0.0166	0.0166	CcSEcCtD
Phendimetrazine—Anorexia—Fludarabine—lymphatic system cancer	0.0166	0.0166	CcSEcCtD
Phendimetrazine—Sweating—Vincristine—lymphatic system cancer	0.016	0.016	CcSEcCtD
Phendimetrazine—Nausea—Mechlorethamine—lymphatic system cancer	0.0159	0.0159	CcSEcCtD
Phendimetrazine—Abdominal pain—Teniposide—lymphatic system cancer	0.0156	0.0156	CcSEcCtD
Phendimetrazine—Sweating—Mitoxantrone—lymphatic system cancer	0.0155	0.0155	CcSEcCtD
Phendimetrazine—Decreased appetite—Fludarabine—lymphatic system cancer	0.0151	0.0151	CcSEcCtD
Phendimetrazine—Constipation—Fludarabine—lymphatic system cancer	0.0149	0.0149	CcSEcCtD
Phendimetrazine—Flushing—Carmustine—lymphatic system cancer	0.0145	0.0145	CcSEcCtD
Phendimetrazine—Diarrhoea—Teniposide—lymphatic system cancer	0.0135	0.0135	CcSEcCtD
Phendimetrazine—Vision blurred—Carmustine—lymphatic system cancer	0.0128	0.0128	CcSEcCtD
Phendimetrazine—Tremor—Carmustine—lymphatic system cancer	0.0128	0.0128	CcSEcCtD
Phendimetrazine—Agitation—Carmustine—lymphatic system cancer	0.0125	0.0125	CcSEcCtD
Phendimetrazine—Headache—Teniposide—lymphatic system cancer	0.0124	0.0124	CcSEcCtD
Phendimetrazine—Anorexia—Bleomycin—lymphatic system cancer	0.0121	0.0121	CcSEcCtD
Phendimetrazine—Agitation—Vincristine—lymphatic system cancer	0.012	0.012	CcSEcCtD
Phendimetrazine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.0119	0.0119	CcSEcCtD
Phendimetrazine—Diarrhoea—Fludarabine—lymphatic system cancer	0.0119	0.0119	CcSEcCtD
Phendimetrazine—Nausea—Teniposide—lymphatic system cancer	0.0117	0.0117	CcSEcCtD
Phendimetrazine—Decreased appetite—Bleomycin—lymphatic system cancer	0.0111	0.0111	CcSEcCtD
Phendimetrazine—Headache—Fludarabine—lymphatic system cancer	0.0109	0.0109	CcSEcCtD
Phendimetrazine—Tachycardia—Carmustine—lymphatic system cancer	0.0109	0.0109	CcSEcCtD
Phendimetrazine—Anorexia—Carmustine—lymphatic system cancer	0.0106	0.0106	CcSEcCtD
Phendimetrazine—Nausea—Fludarabine—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Phendimetrazine—Anorexia—Vincristine—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Phendimetrazine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Phendimetrazine—Insomnia—Carmustine—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.01	0.01	CcSEcCtD
Phendimetrazine—Anorexia—Mitoxantrone—lymphatic system cancer	0.00986	0.00986	CcSEcCtD
Phendimetrazine—Decreased appetite—Carmustine—lymphatic system cancer	0.00967	0.00967	CcSEcCtD
Phendimetrazine—Insomnia—Vincristine—lymphatic system cancer	0.00961	0.00961	CcSEcCtD
Phendimetrazine—Constipation—Carmustine—lymphatic system cancer	0.00951	0.00951	CcSEcCtD
Phendimetrazine—Decreased appetite—Vincristine—lymphatic system cancer	0.00923	0.00923	CcSEcCtD
Phendimetrazine—Constipation—Vincristine—lymphatic system cancer	0.00908	0.00908	CcSEcCtD
Phendimetrazine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00899	0.00899	CcSEcCtD
Phendimetrazine—Constipation—Mitoxantrone—lymphatic system cancer	0.00884	0.00884	CcSEcCtD
Phendimetrazine—Abdominal pain—Carmustine—lymphatic system cancer	0.00879	0.00879	CcSEcCtD
Phendimetrazine—Dysuria—Methotrexate—lymphatic system cancer	0.00847	0.00847	CcSEcCtD
Phendimetrazine—Abdominal pain—Vincristine—lymphatic system cancer	0.0084	0.0084	CcSEcCtD
Phendimetrazine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00818	0.00818	CcSEcCtD
Phendimetrazine—Sweating—Methotrexate—lymphatic system cancer	0.00775	0.00775	CcSEcCtD
Phendimetrazine—Diarrhoea—Carmustine—lymphatic system cancer	0.00761	0.00761	CcSEcCtD
Phendimetrazine—Nausea—Bleomycin—lymphatic system cancer	0.00757	0.00757	CcSEcCtD
Phendimetrazine—Dizziness—Carmustine—lymphatic system cancer	0.00736	0.00736	CcSEcCtD
Phendimetrazine—Diarrhoea—Vincristine—lymphatic system cancer	0.00727	0.00727	CcSEcCtD
Phendimetrazine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00708	0.00708	CcSEcCtD
Phendimetrazine—Dizziness—Vincristine—lymphatic system cancer	0.00702	0.00702	CcSEcCtD
Phendimetrazine—Headache—Carmustine—lymphatic system cancer	0.00697	0.00697	CcSEcCtD
Phendimetrazine—Headache—Vincristine—lymphatic system cancer	0.00665	0.00665	CcSEcCtD
Phendimetrazine—Nausea—Carmustine—lymphatic system cancer	0.00661	0.00661	CcSEcCtD
Phendimetrazine—Headache—Mitoxantrone—lymphatic system cancer	0.00648	0.00648	CcSEcCtD
Phendimetrazine—Nausea—Vincristine—lymphatic system cancer	0.00631	0.00631	CcSEcCtD
Phendimetrazine—Nausea—Mitoxantrone—lymphatic system cancer	0.00614	0.00614	CcSEcCtD
Phendimetrazine—Vision blurred—Methotrexate—lymphatic system cancer	0.00595	0.00595	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00498	0.00498	CcSEcCtD
Phendimetrazine—Anorexia—Methotrexate—lymphatic system cancer	0.00491	0.00491	CcSEcCtD
Phendimetrazine—Insomnia—Methotrexate—lymphatic system cancer	0.00466	0.00466	CcSEcCtD
Phendimetrazine—Decreased appetite—Methotrexate—lymphatic system cancer	0.00448	0.00448	CcSEcCtD
Phendimetrazine—Abdominal pain—Methotrexate—lymphatic system cancer	0.00407	0.00407	CcSEcCtD
Phendimetrazine—Diarrhoea—Methotrexate—lymphatic system cancer	0.00353	0.00353	CcSEcCtD
Phendimetrazine—Dizziness—Methotrexate—lymphatic system cancer	0.00341	0.00341	CcSEcCtD
Phendimetrazine—Headache—Methotrexate—lymphatic system cancer	0.00323	0.00323	CcSEcCtD
Phendimetrazine—Nausea—Methotrexate—lymphatic system cancer	0.00306	0.00306	CcSEcCtD
